Last reviewed · How we verify

NCT05513521

Speed-specific Training and Ultrasound

Completed NA Last updated 4 January 2023
What this trial tests

NA trial testing High-velocity interval training in High-Intensity Interval Training in 25 participants. Completed in 12 December 2022.

Timeline
18 August 2022
Primary endpoint
12 December 2022
12 December 2022

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment25
Start date18 August 2022
Primary completion12 December 2022
Estimated completion12 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 55 to 90, any sex, with High-Intensity Interval Training or Resistance Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators propose to compare the effects of a 12-week load resistance training program to a velocity resistance training program on ultrasound measures of quadriceps muscle quality in a healthy, older adult population. As secondary measures, The investigators propose to compare the effects of these exercise programs on maximal strength, power, and functional movements such as the chair sit-to-stand and gait speed. Further, The investigators will evaluate the impact of each protocol on cognitive function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for High-Intensity Interval Training

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05513521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing